Table 1 Demographic and clinical details.

From: Immunosenescence-related T cell phenotypes, structural brain imaging, and cognitive impairment in patients with schizophrenia: a moderated mediation analysis

 

SCZ (n = 65)

HC (n = 39)

χ2/t

p

Biological sex (M/F)

38/27

22/17

0.042

0.838

Age (years)

53.04 ± 7.87

50.97 ± 6.28

–1.397

0.166

Education (years)

11.58 ± 2.83

11.03 ± 3.67

–0.871

0.386

BMI (kg/m2)

24.66 ± 4.07

24.40 ± 2.85

–0.325

0.746

h-CRP (mg/L)

1.67 ± 1.41

1.94 ± 2.41

0.669

0.505

Age of psychosis onset (years)

23.57 ± 7.91

–

–

–

Duration (years)

29.62 ± 9.97

–

–

–

CPZ (mg)

529.75 ± 305.12

–

–

–

Clozapine dosage (mg)

182.30 ± 133.21

–

–

–

PANSS score

 Total

66.22 ± 11.97

–

–

–

 Positive

15.70 ± 6.08

–

–

–

 Negative

24.63 ± 6.17

–

–

–

 General

25.88 ± 6.02

–

–

–

  1. The demographic and clinical measures were not significantly different between the SCZ and HC groups. BMI body mass index, h-CRP high-sensitivity C-reactive protein, CPZ chlorpromazine equivalent, PANSS Positive and Negative Syndrome Scale, SCZ schizophrenia, HC healthy control.
Back to article page